In this Hangout, we will discuss when a small business should contact the FDA, and what formal and informal mechanisms exist for device, drug, biologic, and diagnostic developers to obtain early advice from the FDA.
{iframe}https://plus.google.com/u/0/events/cf607e81kfl7hh67hijq5nodl0o{/iframe}